Summary
In 17 type-I diabetic patients on continuous s.c. insulin infusion (CSII) therapy, potential interrelationships between fasting levels of blood glucose (BG), serum free insulin (free IRI), total (free and bound) insulin (total IRI) and insulinbinding immunglobulin G (IgGI) were evaluated. There was no consistent relationship between the basal s.c. infused insulin dosages and the associated insulinaemia or glycaemia. A significant inverse correlation was found between the fasting levels of serum free IRI and BG (P<0.005). On the basis of this interrelationship, a target range of 90–110 mg/dl for fasting BG during CSII treatment is proposed.
Similar content being viewed by others
References
Bar RS, Gorden P, Roth J, Siebert C (1977) Insulin receptors in patients with insulinomas: changes in receptor affinity and concentration. J Clin Endocrinol Metab 44:120–1213
Berger M, Cüppers HJ, Hegner H, Jörgens V, Berchtold P (1982) Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 5:77–91
Berger M, Sonnenberg GE, Chantelau EA (1982) Insulin pump treatment for diabetes: some questions can be answered already. Clin Physiol 2:351–355
Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P, Gerich J (1983) Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32:134–141
Editorial (1982) Type I diabetes ... regimens, targets, and caveats. Diabetes Care 5:547–552
Gale EAM, Kurtz AB, Tattersall RB (1980) In search of the Somogyi effect. Lancet II:279–282
Gerich JE, Rizza RA, Verdonk CA (1981) Effect of plasma glucose concentration on production, utilization, and clearence of glucose in man. Proceedings of the International Symposium on Artificial Systems for Insulin Delivery, 20–23 Sept 1981, Assisi (Perugia), Italy; abstr. 51
Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH (1975) Proinsulin, insulin, and c-peptide concentrations in human portal and peripheral blood. J Clin Invest 55:1278–1283
Kruse V (1981) Effect of insulin-binding antibodies on free insulin in plasma and tissue after subcutaneous injection. In: Keck K, Erb P (eds) Basic and clinical aspects of immunity to insulin. Walter de Gruyter & Co., New York Berlin
Lock DR, Rigg LA (1981) Hypoglycaemic coma associated with subcutaneous insulin infusion by portable pump. Diabetes Care 4:389–391
Malone JI, Root AW (1981) Plasma free insulin concentrations: keystone to effective management of diabetes mellitus in children. J Pediatr 99:862–867
Pedersen O, Beck-Nielsen H, Heding L (1980) Increased insulin receptors after exercise in patients with insulin-dependent diabetes mellitus. N Engl J Med 302:886–892
Peterson CM (1982) History and goals of insulin treatment (Symposium on optimal insulin delivery). Diabetes Care 5, Suppl 1:1–5
Pickup JC (1982) Continuous subcutaneous insulin infusion. Br Med J 285:49–50
Pickup JC, Viberti GC, Bilous RW, Keen H, Alberti KGMM, Home PD, Binder C (1982) Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia 22:175–179
Raskin P (1982) Treatment of type I diabetes with portable insulin infusion devices. Diabetes Care 5, Suppl 1:48–52
Skyler JS, Seigler DE, Reeves ML (1982) Optimizing pumped insulin delivery. Diabetes Care 5:135–139
Sonnenberg GE, Chantelau E, Berger M (1981) Ein neues therapeutisches Prinzip in der Diabetologie: kontinuierliche Insulin-Infusion mittels portabler Pumpen. Dtsch Med Wochenschr 106:891–893
Sonnenberg GE, Chantelau E, Berger M (1982) Mismanagement of insulin pumps. Diabetes Care 5:145 (letter)
Unger RH (1982) Meticulous control of diabetes: benefits, risks and precautions. Diabetes 31:479–483
Author information
Authors and Affiliations
Additional information
This study was in part presented at the 18th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Budapest, Hungary, 1–4 September 1982
Rights and permissions
About this article
Cite this article
Chantelau, E.A., Sonnenberg, G.E., Best, F. et al. Target fasting glycaemia for pump-treated type-i diabetics. Klin Wochenschr 62, 328–330 (1984). https://doi.org/10.1007/BF01716450
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01716450